Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma, Papillary

Clinical trial condition

Adenocarcinoma, Papillary

Explore clinical trials studying Adenocarcinoma, Papillary. Study availability and eligibility vary by location and protocol.

138 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma, Papillary trial results

Completed

Overdiagnosis of Thyroid Cancer in the Marne and Ardennes Departments of France From 1975 to 2014

NCT03623516

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: Damien JOLLY Reims, France

View Trial Details

Completed

Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

NCT01502410

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +31 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Southern California Permanente Medical Group Downey, California, United States

View all 92 locations

View Trial Details

Completed

Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer

NCT01811212

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +28 more
Locations: MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer

NCT03359668

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: Not specified

View Trial Details

Completed

Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma

NCT02561533

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: Aarhus University Hospital Aarhus C, Denmark

View Trial Details

Completed

Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer

NCT02442661

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: Rebecca J Guigli Aurora, Colorado, United States

View Trial Details

Completed

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

NCT01927887

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +20 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Thalidomide in Treating Patients With Thyroid Cancer

NCT00026533

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +19 more
Locations: Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

NCT00095836

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

NCT00519896

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +26 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details